Reviewing Mannatech (MTEX) and Its Rivals

Mannatech (NASDAQ:MTEX) is one of 55 public companies in the “Personal Care Products” industry, but how does it contrast to its competitors? We will compare Mannatech to similar businesses based on the strength of its valuation, dividends, analyst recommendations, profitability, earnings, institutional ownership and risk.

Insider and Institutional Ownership

13.0% of Mannatech shares are held by institutional investors. Comparatively, 48.6% of shares of all “Personal Care Products” companies are held by institutional investors. 47.5% of Mannatech shares are held by insiders. Comparatively, 11.7% of shares of all “Personal Care Products” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations for Mannatech and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mannatech	1	0	0	0	1.00
Mannatech Competitors	901	2937	3662	229	2.42

As a group, “Personal Care Products” companies have a potential upside of 1.82%. Given Mannatech’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Mannatech has less favorable growth aspects than its competitors.

Profitability

This table compares Mannatech and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mannatech	-6.90%	-2,383.34%	-24.43%
Mannatech Competitors	-4.68%	-66.64%	-0.50%

Valuation & Earnings

This table compares Mannatech and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Mannatech	$108.04 million	-$15.21 million	-2.19
Mannatech Competitors	$7.93 billion	$1.11 billion	8.92

Mannatech’s competitors have higher revenue and earnings than Mannatech. Mannatech is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Mannatech has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500. Comparatively, Mannatech’s competitors have a beta of 0.80, suggesting that their average stock price is 20% less volatile than the S&P 500.

Summary

Mannatech competitors beat Mannatech on 11 of the 12 factors compared.

About Mannatech

Mannatech, Incorporated develops and markets nutritional supplements, health and wellness products, and personal-care products through a direct-selling business model. Its product offerings have included dietary supplements, functional nutrition products, weight-management formulas, and skin-care products, with an emphasis on ingredients intended to support general wellness and healthy aging. The company is best known for its Ambrotose product line, which incorporates plant-sourced polysaccharides, as well as related nutritional supplements and wellness programs.